| Dr Guaroa D Ariza, MD | |
|
7 Belgrade St, Youngstown, OH 44505-1817 | |
| (330) 759-0260 | |
| (330) 759-1259 |
| Full Name | Dr Guaroa D Ariza |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 7 Belgrade St, Youngstown, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770560369 | NPI | - | NPPES |
| 0259143 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 37008 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Guaroa D Ariza, MD 7 Belgrade St, Youngstown, OH 44505-1817 Ph: (330) 759-0260 | Dr Guaroa D Ariza, MD 7 Belgrade St, Youngstown, OH 44505-1817 Ph: (330) 759-0260 |
News Archive
"The U.S. development community is pronouncing itself 'thrilled' with the Obama administration's recently unveiled new development policy," Politico's Laura Rozen reports on her blog, which examines reaction to President Barack Obama's speech at the U.N. Summit on the Millennium Development Goals (MDGs) last week.
Findings by a Saint Louis University research team led by the scientist who discovered Sly Syndrome 32 years ago point to a new direction for research into the rare genetic disorder that can cause bone deformities, vision and hearing loss, mental retardation and death in children.
Biotechnology company MabCure, Inc. today announced the company has filed a provisional patent application for its ovarian cancer diagnostic antibodies with the U.S. Patent and Trademark Office. The filing was based on positive results of a recent study that showed MabCure's tumor-specific monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent) and distinguished it from benign tumors of the ovaries or healthy blood obtained from men and women.
An emerging discipline of noninvasive cardiac imaging, molecular imaging, has evolved constantly in the last few years and is increasingly being translated from the preclinical to the clinical level.
Scientists have identified a gene that could potentially open the door for the development of new treatments of the lethal disease sepsis.
› Verified 5 days ago
Dr. Robert L Gilliland, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4247 Stratford Rd, Youngstown, OH 44512 Phone: 330-519-5192 Fax: 330-782-6652 | |
Michael Kentris, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1044 Belmont Ave, Youngstown, OH 44504 Phone: 330-480-3285 Fax: 330-480-2946 | |
Dr. John R Becker Jr., MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 550 Parmalee Ave, Ste 200, Youngstown, OH 44510 Phone: 330-746-4001 Fax: 330-480-2042 | |
Unknown Adityanjee, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1044 Belmont Ave, Youngstown, OH 44504 Phone: 330-480-3655 Fax: 330-480-2900 | |
Krishna Devulapalli, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 615 Churchill Hubbard Rd, Youngstown, OH 44505 Phone: 330-758-4515 Fax: 330-758-5121 | |
Antonia Bogyi, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2031 Belmont Ave, Youngstown, OH 44505 Phone: 330-740-9200 | |
Mrs. Andrea Lynn Svoboda, NP-C Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1053 Belmont Ave, Youngstown, OH 44504 Phone: 330-480-7350 Fax: 330-746-7436 |